Publications
- Newest First
- Most Cited
- Most Discussed
Showing 1 - 100 results of 5,823 publications
2024
- Integrated group antenatal and pediatric care in Haiti: A comprehensive care accompaniment modelMeredith Casella Jean- Baptists, March Julmisse, Oluwatosin O Adeyemo, Thamar Monide Vital Julmiste, Jessica L. Illuzzi
- The influence of lifestyle factors on serum etonogestrel concentrations among contraceptive implant usersLazorwitz A, Sheeder J, Teal S. The influence of lifestyle factors on serum etonogestrel concentrations among contraceptive implant users. Contraception 2024, 110539. PMID: 39002624, DOI: 10.1016/j.contraception.2024.110539.
- Hypothalamic hormone deficiency enables physiological anorexia in ground squirrels during hibernationMohr S, Dai Pra R, Platt M, Feketa V, Shanabrough M, Varela L, Kristant A, Cao H, Merriman D, Horvath T, Bagriantsev S, Gracheva E. Hypothalamic hormone deficiency enables physiological anorexia in ground squirrels during hibernation. Nature Communications 2024, 15: 5803. PMID: 38987241, PMCID: PMC11236985, DOI: 10.1038/s41467-024-49996-2.
- Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patientsC. M, Lavi E, Altwerger G, Lin Z, Ratner E. Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients. PLOS ONE 2024, 19: e0305273. PMID: 38976671, PMCID: PMC11230535, DOI: 10.1371/journal.pone.0305273.
- Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinomaMcNamara B, Greenman M, Bellone S, Santin L, Demirkiran C, Mutlu L, Hartwich T, Yang-Hartwich Y, Ratner E, Schwartz P, Santin A. Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma. Gynecologic Oncology 2024, 189: 16-23. PMID: 38981151, DOI: 10.1016/j.ygyno.2024.07.002.
- Non-invasive preimplantation genetic testing for aneuploidy: is the promise real?Volovsky M, Scott R, Seli E. Non-invasive preimplantation genetic testing for aneuploidy: is the promise real? Human Reproduction 2024, deae151. PMID: 38970367, DOI: 10.1093/humrep/deae151.
- Regulated circRNA nuclear export in neuronal differentiationLi D, Huang Y. Regulated circRNA nuclear export in neuronal differentiation. Trends In Cell Biology 2024 PMID: 38964955, DOI: 10.1016/j.tcb.2024.06.005.
- O-294 Human oocyte survival, early embryo development, metabolic fingerprinting, and pregnancy outcomes following ultra-rapid or standard vitrification and thawingAydin B, Hudkova D, Maggiotto G, Kal N, Osmanllari U, Unsal E, Baltaci V, Aktuna S, Yonar D, Dorofeyeva U, Kotliarova E, Vitushynska M, Misyura Y, Yetim I, Babarikova V. O-294 Human oocyte survival, early embryo development, metabolic fingerprinting, and pregnancy outcomes following ultra-rapid or standard vitrification and thawing. Human Reproduction 2024, 39: deae108.351. DOI: 10.1093/humrep/deae108.351.
- O-272 Preimplantation genetic testing of the first polar body is useful for predicting embryo euploidy: data from 1,836 donor oocytesMaggiotto G, Aydin B, Strelko H, Hudkova D, Unsal E, Kal N, Yetim I, Misyura Y, Kotliarova E, Vitushynska M, Dorofeyeva U. O-272 Preimplantation genetic testing of the first polar body is useful for predicting embryo euploidy: data from 1,836 donor oocytes. Human Reproduction 2024, 39: deae108.319. DOI: 10.1093/humrep/deae108.319.
- Periviability for the Ob-Gyn HospitalistDave E, Kohari K, Cross S. Periviability for the Ob-Gyn Hospitalist. Obstetrics And Gynecology Clinics Of North America 2024 DOI: 10.1016/j.ogc.2024.05.008.
- EVALUATING DAY 5 VERSUS DAY 6 BLASTULATION RATES AMONG FRESH VERSUS FROZEN DONOR EGG CYCLESDotterweich K, Gill P, Reig A, Whitehead C, Werner M, Seli E. EVALUATING DAY 5 VERSUS DAY 6 BLASTULATION RATES AMONG FRESH VERSUS FROZEN DONOR EGG CYCLES. Fertility And Sterility 2024, 122: e24-e25. DOI: 10.1016/j.fertnstert.2024.05.041.
- Current Status of Ovarian and Endometrial Biomarkers in Predicting ART OutcomesVolovsky M, Seifer D. Current Status of Ovarian and Endometrial Biomarkers in Predicting ART Outcomes. Journal Of Clinical Medicine 2024, 13: 3739. PMID: 38999305, PMCID: PMC11242103, DOI: 10.3390/jcm13133739.
- Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2Mutlu L, McNamara B, Bellone S, Manavella D, Demirkiran C, Greenman M, Verzosa M, Buza N, Hui P, Hartwich T, Harold J, Yang-Hartwich Y, Zipponi M, Altwerger G, Ratner E, Huang G, Clark M, Andikyan V, Azodi M, Schwartz P, Santin A. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2. Clinical & Experimental Metastasis 2024, 1-11. PMID: 38909139, DOI: 10.1007/s10585-024-10297-z.
- Developing an interactive reproductive health equity session for pre-clerkship medical studentsTiako M, Aguilar G, Adeyemo O, Reynolds H, Campbell K, Stanwood N, Galerneau F. Developing an interactive reproductive health equity session for pre-clerkship medical students. Medical Education Online 2024, 29: 2364984. PMID: 38903002, PMCID: PMC11195450, DOI: 10.1080/10872981.2024.2364984.
- Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analysesRoque D, Siegel E, Buza N, Bellone S, Huang G, Altwerger G, Andikyan V, Clark M, Azodi M, Schwartz P, Rao G, Ratner E, Santin A. Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses. BJC Reports 2024, 2: 43. DOI: 10.1038/s44276-024-00067-5.
- Stimulation Therapy to Induce Mothers (STIM): Protocol for a Multicenter Randomized Controlled Trial (Preprint)Tortal D, Shabanova V, Taylor S, Xu X, McAdow M, Stetson B, McCollum S, Sanchez E, Adjakple A, Leventhal J, Son M. Stimulation Therapy to Induce Mothers (STIM): Protocol for a Multicenter Randomized Controlled Trial (Preprint). JMIR Research Protocols 2024 DOI: 10.2196/63463.
- Kisspeptin signaling in astrocytes modulates the reproductive axisTorres E, Pellegrino G, Granados-Rodríguez M, Fuentes-Fayos A, Velasco I, Coutteau-Robles A, Legrand A, Shanabrough M, Perdices-Lopez C, Leon S, Yeo S, Manchishi S, Sánchez-Tapia M, Navarro V, Pineda R, Roa J, Naftolin F, Argente J, Luque R, Chowen J, Horvath T, Prevot V, Sharif A, Colledge W, Tena-Sempere M, Romero-Ruiz A. Kisspeptin signaling in astrocytes modulates the reproductive axis. Journal Of Clinical Investigation 2024 PMID: 38861336, DOI: 10.1172/jci172908.
- Understanding how space travel affects the female reproductive system to the Moon and beyondMathyk B, Imudia A, Quaas A, Halicigil C, Karouia F, Avci P, Nelson N, Guzeloglu-Kayisli O, Denbo M, Sanders L, Scott R, Basar M, Guevara-Cerdán A, Strug M, Monseur B, Kayisli U, Szewczyk N, Mason C, Young S, Tasoglu S, Costes S, Beheshti A. Understanding how space travel affects the female reproductive system to the Moon and beyond. Npj Women's Health 2024, 2: 20. DOI: 10.1038/s44294-024-00009-z.
- Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations.Manrai P, McHenry A, Sun T, Santin A, Ratner E, Lin D, Elvin J, Hui P, Buza N. Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations. International Journal Of Gynecological Pathology 2024 PMID: 38914011, DOI: 10.1097/pgp.0000000000001050.
- Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort studyGroup T, Scholtens D, LeBlanc E, Vesco K, Amy D, Bays K, Massimino S, Robinson S, Schell K, Walters G, Hillier T, Oshiro C, Cordero S, Howick C, Kim L, Martinez Y, Pishchalenko O, Wastlova V, Zork N, Mourad M, Lonier J, Reddy U, Acevedo J, Castillo J, Gomez M, Peguero B, Facco F, Feghali M, Bocan H, Stramowski S, Powe C, Edlow A, Barth W, Nathan D, Azevedo R, Baez A, Iroajanma C, Larkin M, Maya J, Michalopolous C, Neamonitaki N, Thangthaeng N, Yee L, Lowe W, Grobman W, Szmuilowicz E, Aguirre A, Guevara E, Mallett G, Matos S, Tyagi S, Spadola A, Catalano P, Azimirad A, Werner E, Rouse D, Malloy M, Parra F, Sherr J, Merriam A, Bitterman S, Considine E, Leventhal J, Perley L, Rink L, Steffen A, Thompson B, Zgorski M, Steffes M, Arends V, Killeen A, Siddique J, Bustamante P, Cheung Y, Freeze C, Grott T, Kuang A, Tull M, Linder B. Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study. BMJ Open 2024, 14: e084216. PMID: 38851233, PMCID: PMC11163666, DOI: 10.1136/bmjopen-2024-084216.
- Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.Denoble A, Vazquez-Benitez G, Sheth S, Ackerman-Banks C, DeSilva M, Zhu J, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Weintraub E, Kharbanda E, Lipkind H. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstetrics And Gynecology 2024 PMID: 38843526, DOI: 10.1097/aog.0000000000005632.
- TikTok misinformation and user engagement in female pelvic floor conditionsStephan A, Hauc S, Marks V, Bercik R, Rickey L. TikTok misinformation and user engagement in female pelvic floor conditions. Neurourology And Urodynamics 2024 PMID: 38828831, DOI: 10.1002/nau.25519.
- Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.Rogers JH, Rosen A, Reyes JM, Ketkar S, Conneely SE, Gupta R, Yang L, Miller MB, Medrano G, Aguilar R, Uchenda N, Goodell MA, Rau RE. Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia. Exp Hematol 2024, 135: 104248. PMID: 38834136, DOI: 10.1016/j.exphem.2024.104248.
- Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer TherapyDanziger M, Noble H, Roque D, Xu F, Rao G, Santin A. Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy. Advances In Experimental Medicine And Biology 2024, 1452: 1-19. PMID: 38805122, DOI: 10.1007/978-3-031-58311-7_1.
- Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026).Erickson B, Enserro D, Lankes H, Dockery L, ghamande S, Oliver M, Gressel G, Castellano T, Ratner E, Deery A, Bishop E, Bradford L, Thomes Pepin J, Burton E, Blank S, Santin A, Havrilesky L, Aghajanian C, Nickles Fader A, Powell M. Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026). Journal Of Clinical Oncology 2024, 42: tps5641-tps5641. DOI: 10.1200/jco.2024.42.16_suppl.tps5641.
- Evolution of biotechnological advances and regenerative therapies for endometrial disorders: a systematic reviewRodríguez-Eguren A, Bueno-Fernandez C, Gómez-Álvarez M, Francés-Herrero E, Pellicer A, Bellver J, Seli E, Cervelló I. Evolution of biotechnological advances and regenerative therapies for endometrial disorders: a systematic review. Human Reproduction Update 2024, dmae013. PMID: 38796750, DOI: 10.1093/humupd/dmae013.
- Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on CareKaufman J, Yonkers K, Maltz C, Friedhoff C, Tobon A, Mele A, Tessier-Kay M, Grechukhina O, Lipkind H, Byatt N, Forray A. Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on Care. Journal Of Women's Health 2024 PMID: 38770764, DOI: 10.1089/jwh.2023.0822.
- Entering the golden age for antibody-drug conjugates in gynecologic cancerGreenman M, McNamara B, Mutlu L, Santin A. Entering the golden age for antibody-drug conjugates in gynecologic cancer. Oncoscience 2024, 11: 51-52. PMID: 38770444, PMCID: PMC11104406, DOI: 10.18632/oncoscience.604.
- Medical Management of Endometriosis in Adolescent and Young Adult Women: A Review of 91 Cases of Biopsy-Confirmed EndometriosisLi H, Esencan E, Song Y, Taylor H, Cho Y, Vash-Margita A. Medical Management of Endometriosis in Adolescent and Young Adult Women: A Review of 91 Cases of Biopsy-Confirmed Endometriosis. Journal Of Obstetrics And Gynaecology Canada 2024, 46: 102562. PMID: 38759792, DOI: 10.1016/j.jogc.2024.102562.
- A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.Kendall P, Bresnitz W, Huang J, Sheeder J, Lazorwitz A. A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals. Contraception 2024, 110486. PMID: 38754757, DOI: 10.1016/j.contraception.2024.110486.
- Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7Coenen C, Hidalgo T, Lynn T, Jones D, Salmon J, Chamley L, Abrahams V. Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7. Journal Of Reproductive Immunology 2024, 164: 104255. PMID: 38797133, DOI: 10.1016/j.jri.2024.104255.
- ARID1A in Gynecologic Precancers and CancersMorgan J, Jaferi N, Shonibare Z, Huang G. ARID1A in Gynecologic Precancers and Cancers. Reproductive Sciences 2024, 1-13. PMID: 38740655, DOI: 10.1007/s43032-024-01585-w.
- Reply: Consecutive euploid blastocyst transfers currently represent the best available model for investigating the true prevalence of recurrent implantation failure (RIF), a rare pathology at bestAta B, Gill P, Cimadomo D, Ubaldi F, Garcia-Velasco J, Seli E. Reply: Consecutive euploid blastocyst transfers currently represent the best available model for investigating the true prevalence of recurrent implantation failure (RIF), a rare pathology at best. Human Reproduction 2024, 39: 1575-1576. PMID: 38741229, DOI: 10.1093/humrep/deae096.
- The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviewsYounis J, Taylor H. The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews. Frontiers In Endocrinology 2024, 15: 1397279. PMID: 38800489, PMCID: PMC11116636, DOI: 10.3389/fendo.2024.1397279.
- Pilot PET study of vaginally administered bioadhesive nanoparticles in cynomolgus monkeys: Kinetics and safety evaluationGrun M, Honhar P, Wang Y, Rossano S, Khang M, Suh H, Fowles K, Kliman H, Cavaliere A, Carson R, Marquez‐Nostra B, Saltzman W. Pilot PET study of vaginally administered bioadhesive nanoparticles in cynomolgus monkeys: Kinetics and safety evaluation. Bioengineering & Translational Medicine 2024 DOI: 10.1002/btm2.10661.
- Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trialHerlihy N, Cakiroglu Y, Whitehead C, Reig A, Tiras B, Scott R, Seli E. Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial. Human Reproduction 2024, 39: 1495-1503. PMID: 38725194, DOI: 10.1093/humrep/deae093.
- Laparoscopic pancreatic peritonectomy with splenectomy for recurrent ovarian cancer: a novel approach to achieve R0 while preserving the pancreatic body and tailVlamis C, Abozenah Y, Pebley N, Chang Y, McNamara B, Altwerger G. Laparoscopic pancreatic peritonectomy with splenectomy for recurrent ovarian cancer: a novel approach to achieve R0 while preserving the pancreatic body and tail. International Journal Of Gynecological Cancer 2024, ijgc-2024-005358. PMID: 38724238, DOI: 10.1136/ijgc-2024-005358.
- Conventional laparoscopic resection of platinum-sensitive recurrent oligometastatic ovarian cancer lesion in the interaortocaval regionAbozenah Y, Vlamis C, Ghazarian M, Harold J, Tymon-Rosario J, Altwerger G. Conventional laparoscopic resection of platinum-sensitive recurrent oligometastatic ovarian cancer lesion in the interaortocaval region. International Journal Of Gynecological Cancer 2024, ijgc-2024-005269. PMID: 38719278, DOI: 10.1136/ijgc-2024-005269.
- Chronicling menstrual cycle patterns across the reproductive lifespan with real-world dataCunningham A, Pal L, Wickham A, Prentice C, Goddard F, Klepchukova A, Zhaunova L. Chronicling menstrual cycle patterns across the reproductive lifespan with real-world data. Scientific Reports 2024, 14: 10172. PMID: 38702411, PMCID: PMC11068910, DOI: 10.1038/s41598-024-60373-3.
- Blood pressure responses to handgrip exercise but not apnea or mental stress are enhanced in women with a recent history of preeclampsiaBerbrier D, Adler T, Leone C, Paidas M, Stachenfeld N, Usselman C. Blood pressure responses to handgrip exercise but not apnea or mental stress are enhanced in women with a recent history of preeclampsia. AJP Heart And Circulatory Physiology 2024, 327: h140-h154. PMID: 38700469, DOI: 10.1152/ajpheart.00020.2024.
- Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomasDemirkiran C, Greenman M, Bellone S, McNamara B, Hartwich T, Manavella D, Mutlu L, Zipponi M, Yang-Hartwich Y, Yang K, Ratner E, Schwartz P, Coma S, Pachter J, Santin A. Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas. Gynecologic Oncology 2024, 187: 12-20. PMID: 38703673, DOI: 10.1016/j.ygyno.2024.04.010.
- Quality of Blood Pressure Monitoring During Telehealth Visits for Pregnant Patients at Risk of PreeclampsiaNadkarni S, Oyama S, May H, Adeyemo O. Quality of Blood Pressure Monitoring During Telehealth Visits for Pregnant Patients at Risk of Preeclampsia. Telemedicine Journal And E-Health 2024 PMID: 38752870, DOI: 10.1089/tmj.2024.0003.
- Assessment of a Decade of Change in U.S. Assisted Reproductive Technology Cumulative Live-Birth RatesWang S, Seifer D. Assessment of a Decade of Change in U.S. Assisted Reproductive Technology Cumulative Live-Birth Rates. Obstetrics And Gynecology 2024, 143: 839-848. PMID: 38696814, DOI: 10.1097/aog.0000000000005598.
- The Variation of Chargemaster Price Listings for Urogynecologic Procedures.Baban S, Kasoff M, Kadesh A, Chaudhary R, Lui A, Shi J, Ahluwalia J, White M, Giles D, Petersen TR, Andiman S, Grimes CL. The Variation of Chargemaster Price Listings for Urogynecologic Procedures. Urogynecology (Phila) 2024, 30: 511-518. PMID: 38113134, DOI: 10.1097/SPV.0000000000001426.
- Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiationBonavina G, Mamillapalli R, Krikun G, Zhou Y, Gawde N, Taylor H. Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation. Stem Cell Research & Therapy 2024, 15: 129. PMID: 38693588, PMCID: PMC11064399, DOI: 10.1186/s13287-024-03716-1.
- For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.
- Comparative Readability Assessment of Four Large Language Models in Answers to Common Contraception Questions [ID 2683638]Patel A, Panakam A, Amin K, Doshi R, Patil A, Sheth S. Comparative Readability Assessment of Four Large Language Models in Answers to Common Contraception Questions [ID 2683638]. Obstetrics And Gynecology 2024, 143: 12s-12s. DOI: 10.1097/01.aog.0001013004.01563.47.
- Exploring Effect of Patient Counseling on Mode of Delivery After Cesarean Section [ID 2683575]Pondugula N, Greenberg J, Illuzzi J, Adeyemo O. Exploring Effect of Patient Counseling on Mode of Delivery After Cesarean Section [ID 2683575]. Obstetrics And Gynecology 2024, 143: 54s-54s. DOI: 10.1097/01.aog.0001013692.09625.74.
- Evaluating the Accuracy and Utility of Large Language Models in Answering Common Contraception Questions [ID 2683633]Patel A, Jasani S, AlAshqar A, Panakam A, Amin K, Sheth S. Evaluating the Accuracy and Utility of Large Language Models in Answering Common Contraception Questions [ID 2683633]. Obstetrics And Gynecology 2024, 143: 12s-12s. DOI: 10.1097/01.aog.0001013000.12240.72.
- The effect of acute estrogen suppression on cutaneous endothelium-dependent vasodilation in women with endometriosisColburn A, Leone C, Alexander L, Stachenfeld N. The effect of acute estrogen suppression on cutaneous endothelium-dependent vasodilation in women with endometriosis. Physiology 2024, 39: 421. DOI: 10.1152/physiol.2024.39.s1.421.
- Inhibition of NF-κB Activation Improves Non-Nitric Oxide-Mediated Cutaneous Microvascular Function in Reproductive-Aged Healthy WomenContent V, Williams A, Stachenfeld N, Alexander L. Inhibition of NF-κB Activation Improves Non-Nitric Oxide-Mediated Cutaneous Microvascular Function in Reproductive-Aged Healthy Women. Physiology 2024, 39: 562. DOI: 10.1152/physiol.2024.39.s1.562.
- Sexual Harassment, Abuse, and Discrimination in Obstetrics and GynecologyGupta A, Thompson J, Ringel N, Kim-Fine S, Ferguson L, Blank S, Iglesia C, Balk E, Secord A, Hines J, Brown J, Grimes C. Sexual Harassment, Abuse, and Discrimination in Obstetrics and Gynecology. JAMA Network Open 2024, 7: e2410706. PMID: 38717770, PMCID: PMC11079690, DOI: 10.1001/jamanetworkopen.2024.10706.
- Machine learning in time-lapse imaging to differentiate embryos from young vs old miceYang L, Leynes C, Pawelka A, Lorenzo I, Chou A, Lee B, Heaney J. Machine learning in time-lapse imaging to differentiate embryos from young vs old mice. Biology Of Reproduction 2024, 110: 1115-1124. PMID: 38685607, PMCID: PMC11180621, DOI: 10.1093/biolre/ioae056.
- A common curriculum in obstetrics and gynecology for medical students globallyAtiomo W, Casper G, Symonds I, Obermair H, Gwako G, Vash‐Margita A, Sosa C, Kihara A, Ezimokhai M, Fogarty P. A common curriculum in obstetrics and gynecology for medical students globally. International Journal Of Gynecology & Obstetrics 2024 PMID: 38666747, DOI: 10.1002/ijgo.15544.
- Medication abortion for adolescents in the United States: Strengthening the role of pediatric primary care providersStarosta A, Harris J, Gariepy A, Pathy S, Cron J. Medication abortion for adolescents in the United States: Strengthening the role of pediatric primary care providers. Perspectives On Sexual And Reproductive Health 2024, 56: 76-84. PMID: 38661101, DOI: 10.1111/psrh.12264.
- Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)Donnez J, Becker C, Taylor H, Herrera F, Donnez O, Horne A, Paszkowski M, Petraglia F, Renner S, Patel A, Boolell M, Bestel E, Dolmans M. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3). Human Reproduction 2024, 39: 1208-1221. PMID: 38648863, PMCID: PMC11144970, DOI: 10.1093/humrep/deae076.
- Leukocytospermia does not negatively impact outcomes in in vitro fertilization cycles with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy: findings from 5435 cyclesGill P, Puchalt N, Molinaro T, Werner M, Seli E, Hotaling J, Cheng P. Leukocytospermia does not negatively impact outcomes in in vitro fertilization cycles with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy: findings from 5435 cycles. Journal Of Assisted Reproduction And Genetics 2024, 41: 1213-1219. PMID: 38642270, PMCID: PMC11143111, DOI: 10.1007/s10815-024-03085-x.
- Authors’ ReplyGroup T, Canis M, Abbott J, Abrao M, Al-Jefout M, Bedaiwy M, Benagiano G, Burns K, Carmona F, Chapron C, Critchley H, de Ziegler D, Falcone T, Fazleabas A, Ferrero S, Garcia-Velasco J, Gargett C, Greaves E, Griffith L, Habiba M, Harada T, Hull M, Kaufman Y, Issacson K, Khan K, Kim M, Koninckx P, Lessey B, Martin D, Matsuzaki S, Mishra G, Osuga Y, Petraglia F, Popov A, Roman H, Romano A, Seckin T, Saounders P, Somigliana E, Guo S, Taylor H, Vercellini P, Vigano P, Johnson N. Authors’ Reply. Journal Of Minimally Invasive Gynecology 2024, 31: 624-626. PMID: 38641049, DOI: 10.1016/j.jmig.2024.04.008.
- TLR8‐activating miR‐146a‐3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPSGeorges H, Cassin C, Tong M, Abrahams V. TLR8‐activating miR‐146a‐3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPS. Immunology 2024, 172: 577-587. PMID: 38631842, PMCID: PMC11223956, DOI: 10.1111/imm.13794.
- Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) VaccinationVesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.
- Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervixBellone S, Jeong K, Halle M, Krakstad C, McNamara B, Greenman M, Mutlu L, Demirkiran C, Hartwich T, Yang-Hartwich Y, Zipponi M, Buza N, Hui P, Raspagliesi F, Lopez S, Paolini B, Milione M, Perrone E, Scambia G, Altwerger G, Ravaggi A, Bignotti E, Huang G, Andikyan V, Clark M, Ratner E, Azodi M, Schwartz P, Quick C, Angioli R, Terranova C, Zaidi S, Nandi S, Alexandrov L, Siegel E, Choi J, Schlessinger J, Santin A. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2321898121. PMID: 38625939, PMCID: PMC11046577, DOI: 10.1073/pnas.2321898121.
- Dyadic care to improve postnatal outcomes of birthing people and their infants: A scoping review protocolChoy C, McAdow M, Rosenberg J, Grimshaw A, Martinez-Brockman J. Dyadic care to improve postnatal outcomes of birthing people and their infants: A scoping review protocol. PLOS ONE 2024, 19: e0298927. PMID: 38625992, PMCID: PMC11020692, DOI: 10.1371/journal.pone.0298927.
- ISUOG Practice Guidelines (updated): fetal cardiac screeningCarvalho J, Axt-Fliedner R, Chaoui R, Copel J, Cuneo B, Goff D, Gordin Kopylov L, Hecher K, Lee W, Moon-Grady A, Mousa H, Munoz H, Paladini D, Prefumo F, Quarello E, Rychik J, Tutschek B, Wiechec M, Yagel S. ISUOG Practice Guidelines (updated): fetal cardiac screening. Ultrasound & Functional Diagnostics 2024, 44-70. DOI: 10.24835/1607-0771-270.
- Age-related increase in live-birth rates of first frozen thaw embryo versus first fresh transfer in initial assisted reproductive technology cycles without PGTWang S, Seifer D. Age-related increase in live-birth rates of first frozen thaw embryo versus first fresh transfer in initial assisted reproductive technology cycles without PGT. Reproductive Biology And Endocrinology 2024, 22: 42. PMID: 38615016, PMCID: PMC11015537, DOI: 10.1186/s12958-024-01210-0.
- Moving toward Narrowing the United States Gap in Assisted Reproductive Technology (ART) Racial and Ethnic Disparities in the Next DecadeMahabamunuge J, Seifer D. Moving toward Narrowing the United States Gap in Assisted Reproductive Technology (ART) Racial and Ethnic Disparities in the Next Decade. Journal Of Clinical Medicine 2024, 13: 2224. PMID: 38673497, PMCID: PMC11050514, DOI: 10.3390/jcm13082224.
- Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)Sheth S, Oh J, Bellone S, Siegel E, Greenman M, Mutlu L, McNamara B, Pathy S, Clark M, Azodi M, Altwerger G, Andikyan V, Huang G, Ratner E, Kim D, Iwasaki A, Levi A, Buza N, Hui P, Flaherty S, Schwartz P, Santin A. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147). Clinical Cancer Research 2024, 30: of1-of10. PMID: 38592381, DOI: 10.1158/1078-0432.ccr-23-3639.
- Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndromeBrakta S, Du Q, Chorich L, Hawkins Z, Sullivan M, Ko E, Kim H, Knight J, Taylor H, Friez M, Phillips J, Layman L. Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Molecular And Cellular Endocrinology 2024, 589: 112237. PMID: 38599276, DOI: 10.1016/j.mce.2024.112237.
- High NaCl Concentrations in Water Are Associated with Developmental Abnormalities and Altered Gene Expression in ZebrafishSeli D, Prendergast A, Ergun Y, Tyagi A, Taylor H. High NaCl Concentrations in Water Are Associated with Developmental Abnormalities and Altered Gene Expression in Zebrafish. International Journal Of Molecular Sciences 2024, 25: 4104. PMID: 38612913, PMCID: PMC11012806, DOI: 10.3390/ijms25074104.
- Variation in the mu-opioid receptor gene (OPRM1) moderates the influence of maternal sensitivity on child attachmentTchalova K, Lydon J, Atkinson L, Fleming A, Kennedy J, Lecompte V, Meaney M, Moss E, O’Donnell K, O’Donnell K, Silveira P, Sokolowski M, Steiner M, Bartz J. Variation in the mu-opioid receptor gene (OPRM1) moderates the influence of maternal sensitivity on child attachment. Translational Psychiatry 2024, 14: 181. PMID: 38580654, PMCID: PMC10997775, DOI: 10.1038/s41398-024-02888-x.
- Cancer-associated hypercalcemia signals through the hindbrain to cause anorexiaGrinman D, Dann P, Shanabrough M, Horvath T, Wysolmerski J. Cancer-associated hypercalcemia signals through the hindbrain to cause anorexia. Journal Of Bone Oncology 2024, 45: 100535. DOI: 10.1016/j.jbo.2024.100535.
- 83. Mapping the Consumer Health Information Landscape for Mullerian Anomalies in NNLM Region 4Grimshaw A, MacCarter B, Holt N, Vash-Margita A, Margetts M. 83. Mapping the Consumer Health Information Landscape for Mullerian Anomalies in NNLM Region 4. Journal Of Pediatric And Adolescent Gynecology 2024, 37: 277. DOI: 10.1016/j.jpag.2024.01.090.
- 104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in AdolescentsONeill N, Lynn A, Zamani M, Kuehne A, Miclette K, Rowe E, Fussner L, Vash-Margita A. 104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in Adolescents. Journal Of Pediatric And Adolescent Gynecology 2024, 37: 288-289. DOI: 10.1016/j.jpag.2024.01.111.
- Septic ShockAbdel‐Razeq S. Septic Shock. 2024, 665-695. DOI: 10.1002/9781119820260.ch38.
- Views and values of the uterus across the united states – a multicenter mixed-methods analysis (VUterus)Chang O, Huynh A, Ringel N, Hudson P, Halder G, Winkelman W, Ton J, Davidson E, Meriwether K. Views and values of the uterus across the united states – a multicenter mixed-methods analysis (VUterus). American Journal Of Obstetrics And Gynecology 2024, 230: s1162-s1163. DOI: 10.1016/j.ajog.2024.02.042.
- Sexual harassment, bullying, abuse, and discrimination among obgyn physicians and trainees: a systematic reviewGupta A, Thompson J, Ringel N, Kim-Fine S, Ferguson L, Blank S, Iglesia C, Balk E, Secord A, Hines J, Brown J, Grimes C. Sexual harassment, bullying, abuse, and discrimination among obgyn physicians and trainees: a systematic review. American Journal Of Obstetrics And Gynecology 2024, 230: s1273-s1274. DOI: 10.1016/j.ajog.2024.02.198.
- Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implantClure C, Sheeder J, Lazorwitz A. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant. Contraception 2024, 135: 110442. PMID: 38552822, DOI: 10.1016/j.contraception.2024.110442.
- Substance Use and Anxiety About Pain Among Patients Seeking Abortion ServicesMasten M, Sheeder J, Lazorwitz A. Substance Use and Anxiety About Pain Among Patients Seeking Abortion Services. Cureus 2024, 16: e57034. PMID: 38681459, PMCID: PMC11047799, DOI: 10.7759/cureus.57034.
- Poor ovarian response classification systems in the clinical setting – time for an update?Reig A, Seli E. Poor ovarian response classification systems in the clinical setting – time for an update? Current Opinion In Obstetrics & Gynecology 2024, 36: 192-199. PMID: 38597510, DOI: 10.1097/gco.0000000000000950.
- Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3Sheth S, Oh J, Bellone S, Siegel E, Buza N, Iwasaki A, Santin A. Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3. Cancer Research 2024, 84: 4104-4104. DOI: 10.1158/1538-7445.am2024-4104.
- The effects of pregnancy, its progression, and its cessation on human (maternal) biological agingPham H, Thompson-Felix T, Czamara D, Rasmussen J, Lombroso A, Entringer S, Binder E, Wadhwa P, Buss C, O'Donnell K. The effects of pregnancy, its progression, and its cessation on human (maternal) biological aging. Cell Metabolism 2024, 36: 877-878. PMID: 38521058, DOI: 10.1016/j.cmet.2024.02.016.
- Abstract 575: Identification of SORL1 as a key regulator of chemoresistance in ovarian cancerMansolf M, Jian Z, Bi F, Hartwich T, Yang-Hartwich Y. Abstract 575: Identification of SORL1 as a key regulator of chemoresistance in ovarian cancer. Cancer Research 2024, 84: 575-575. DOI: 10.1158/1538-7445.am2024-575.
- Abstract 2035: A Benzenesulfornamide with potential to improve chemoresponse of ovarian cancer through activation of AMPK and immunogenic cell deathKim J, Montero N, Sharma S, Mansolf M, Yang K, Hartwich T, Yang-Hartwich Y. Abstract 2035: A Benzenesulfornamide with potential to improve chemoresponse of ovarian cancer through activation of AMPK and immunogenic cell death. Cancer Research 2024, 84: 2035-2035. DOI: 10.1158/1538-7445.am2024-2035.
- A modern-day litmus test for the sustainability of daily IVF practice - Alabama supreme court ruling overreaches in asserting that frozen embryos are legally childrenSeifer D. A modern-day litmus test for the sustainability of daily IVF practice - Alabama supreme court ruling overreaches in asserting that frozen embryos are legally children. Reproductive Biology And Endocrinology 2024, 22: 33. PMID: 38509519, PMCID: PMC10956278, DOI: 10.1186/s12958-024-01201-1.
- Ring Chromosome 12Taylor H, Wen J. Ring Chromosome 12. 2024, 191-199. DOI: 10.1007/978-3-031-47530-6_16.
- Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancerMcNamara B, Demirkiran C, Hartwich T, Bellone S, Manavella D, Mutlu L, Greenman M, Zipponi M, Yang-Hartwich Y, Yang K, Ratner E, Schwartz P, Coma S, Pachter J, Santin A. Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer. Gynecologic Oncology 2024, 183: 133-140. PMID: 38493021, DOI: 10.1016/j.ygyno.2024.01.028.
- Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal OutcomesStarosta A, Lundsberg L, Culhane J, Partridge C, Grechukhina O, Son M. Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstetrics And Gynecology 2024, 143: 677-682. PMID: 38484306, DOI: 10.1097/aog.0000000000005554.
- Medical students applying the 4Ms during their first week of schoolWu B, Schwartz M, Marottoli R, Adeyemo O. Medical students applying the 4Ms during their first week of school. Journal Of The American Geriatrics Society 2024 PMID: 38472148, DOI: 10.1111/jgs.18850.
- Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trialTaylor H, Dong L, Haikonen J, Oppelt P, Tamussino K, Wenzl R, Faustmann T, Groettrup-Wolfers E, Ren X, Seitz C. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial. F&S Reports 2024, 5: 189-196. PMID: 38983729, PMCID: PMC11228778, DOI: 10.1016/j.xfre.2024.03.002.
- 360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trialGarcia Y, Gorp T, Konecny G, Leary A, Santin A, Crusz S, Mantia-Smaldone G, Lorusso D, Colombo N, Thomes-Pepin J, Roszak A, Ottevanger P, Beiner M, Cibula D, Leath C, Li L, Method M, Moore K. 360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trial. 2024, a34-a35. DOI: 10.1136/ijgc-2024-esgo.43.
- microRNA-33 controls hunger signaling in hypothalamic AgRP neuronsPrice N, Fernández-Tussy P, Varela L, Cardelo M, Shanabrough M, Aryal B, de Cabo R, Suárez Y, Horvath T, Fernández-Hernando C. microRNA-33 controls hunger signaling in hypothalamic AgRP neurons. Nature Communications 2024, 15: 2131. PMID: 38459068, PMCID: PMC10923783, DOI: 10.1038/s41467-024-46427-0.
- Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patientsGill P, Ata B, Arnanz A, Cimadomo D, Vaiarelli A, Fatemi H, Ubaldi F, Garcia-Velasco J, Seli E. Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patients. Human Reproduction 2024, 39: 974-980. PMID: 38452358, DOI: 10.1093/humrep/deae040.
- Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissuePandya D, Tomita S, Rhenals M, Swierczek S, Reid K, Camacho-Vanegas O, Camacho C, Engelman K, Polukort S, RoseFigura J, Chuang L, Andikyan V, Cohen S, Fiedler P, Sieber S, Shih I, Billaud J, Sebra R, Reva B, Dottino P, Martignetti J. Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue. Gynecologic Oncology 2024, 185: 194-201. PMID: 38452634, DOI: 10.1016/j.ygyno.2024.02.027.
- Uterine fibroid–related infertility: mechanisms and managementDonnez J, Taylor H, Marcellin L, Dolmans M. Uterine fibroid–related infertility: mechanisms and management. Fertility And Sterility 2024, 122: 31-39. PMID: 38453041, DOI: 10.1016/j.fertnstert.2024.02.049.
- Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancerRoque D, Siegel E, Buza N, Bellone S, Silasi D, Huang G, Andikyan V, Clark M, Azodi M, Schwartz P, Rao G, Reader J, Hui P, Tymon-Rosario J, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Santin A. Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer. British Journal Of Cancer 2024, 130: 1073-1073. PMID: 38438590, PMCID: PMC10951353, DOI: 10.1038/s41416-024-02628-4.
- Aging and Adiposity—Focus on Biological Females at Midlife and BeyondRehman A, Lathief S, Charoenngam N, Pal L. Aging and Adiposity—Focus on Biological Females at Midlife and Beyond. International Journal Of Molecular Sciences 2024, 25: 2972. PMID: 38474226, PMCID: PMC10931752, DOI: 10.3390/ijms25052972.
- Abstract IA016: Molecular diversity of uterine serous carcinomaSantin A. Abstract IA016: Molecular diversity of uterine serous carcinoma. Clinical Cancer Research 2024, 30: ia016-ia016. DOI: 10.1158/1557-3265.endo24-ia016.
- Targeting cervical cancer with anti-PD-1 antibodies: what is new?Greenman M, McNamara B, Mutlu L, Santin A. Targeting cervical cancer with anti-PD-1 antibodies: what is new? Expert Opinion On Biological Therapy 2024, 24: 111-114. PMID: 38391293, DOI: 10.1080/14712598.2024.2323596.
- Altered extracellular matrix dynamics is associated with insulin resistance in adolescent children with obesitySlusher A, Nouws J, Tokoglu F, Vash‐Margita A, Matthews M, Fitch M, Shankaran M, Hellerstein M, Caprio S. Altered extracellular matrix dynamics is associated with insulin resistance in adolescent children with obesity. Obesity 2024, 32: 593-602. PMID: 38410080, PMCID: PMC11034857, DOI: 10.1002/oby.23974.
- The Limits of ViabilityPettker C, Turrentine M, Simhan H. The Limits of Viability. Obstetric Anesthesia Digest 2024, 44: 15-16. DOI: 10.1097/01.aoa.0001005316.95573.93.
- Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.Nagy A, Niu N, Ratner E, Hui P, Buza N. Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications. International Journal Of Gynecological Pathology 2024 PMID: 38426544, DOI: 10.1097/pgp.0000000000001024.